1. David aka - TakingthePlunge
    December 14, 2011 @ 2:54 am


    The article Can Platelet Rich Plasma (PRP) Stop Hair Loss and Grow New Hair?, references a case study on a 26 year old hair loss sufferer that suggests that “platelet rich plasma can stop and reverse hair miniaturization caused by androgenic alopecia or male pattern baldness”. However, PRP is still experimental and interest in the procedure seems to be waning.

    The best non-surgical option for balding men remains a combination of Rogaine (minoxidil) and Propecia (finasteride).

    David (TakingThePlunge)

  2. Luke Leonard
    December 12, 2011 @ 7:18 pm

    Would the PRP have Any effects on the genetic male pattern baldness?

  3. Geno Marcovici, Ph.D
    May 23, 2011 @ 12:57 pm

    On the one hand it is encouraging to see new creative methodologies tested to stimulate hair growth in the scalp of patients affected by common pattern hair loss. Moreover, one can appreciate that PRP may have a beneficial role in the setting of autologous transplant surgery. There are numerous studies showing excellent outcomes for PRP in wound healing models. I am also aware of well-controlled data showing potential utility for PRP and MP (micro particles) in diseases ranging from rheumatoid arthritis to liver disease. However, certain caveats come to mind in critically assessing PRP as a stand-alone treatment for pattern hair loss.

    First, and foremost, to my knowledge no peer-reviewed data has thus far been published in the medical literature showing a clinically meaningful outcome in testing PRP as a growth agonist in AGA-miniaturized hair. Second, I am not aware of a definitively demonstrated mechanism of action that would explain such benefit, were it to occur.

    Notwithstanding, in order to establish whether or not PRP represents a therapeutically relevant option for AGA-affected patients, certain steps will need to occur. First, in order to establish safety and efficacy the material will need to be repeatedly tested in well-controlled experimentation. Second, putative growth factors will need to be identified, isolated and validated. Third, the outcome of these experiments will need to be distilled into monograph form and submitted to the peer-reviewed scientific community. It appears that we are at the beginning stages of the aforementioned process and I look forward to monitoring the data as it is generated and disseminated.

Leave a Reply

Your email address will not be published. Required fields are marked *